PHE_Scientific_Provision of purchase of SARS-CoV-2 (2019-nCoV) Spike RBD

A Contract Award Notice
by PUBLIC HEALTH ENGLAND

Source
Contracts Finder
Type
Contract (Products)
Duration
1 year
Value
£26K
Sector
HEALTH
Published
09 Apr 2021
Delivery
02 Apr 2021 to 31 Mar 2022
Deadline
01 Apr 2021 12:00

Concepts

Location

Geochart for 1 buyers and 1 suppliers

1 buyer

1 supplier

Description

The Government must protect the health and well-being of UK citizens. The COVID-19 outbreak is a Public Health Emergency of International Concern (PHEIC) as declared by the World Health Organisation on 30 Jan 2020. The WHO Director General characterised COVID-19 as a pandemic on 11 Mar 2020. PHE discharges its duties as a Category 1 Responder to emergencies on behalf of the Secretary of State for Health within the scope of the Civil Contingencies Act 2004 (CCA 2004). Public Health England (PHE) has awarded a contract for the purchase of Spike RBD Antibody, Antigen Affinity Purified to Stratech Scientific Ltd, via direct award under PHE Microbiology Framework - Lot 2.

Award Detail

1 Stratech Scientific (Ely)
  • Value: £26,094

CPV Codes

  • 33000000 - Medical equipments, pharmaceuticals and personal care products
  • 33696200 - Blood-testing reagents

Indicators

  • Contract is suitable for SMEs.

Other Information

ECM_8180 - Order Form - Provision of purchase of SARS-CoV-2 (2019-nCoV) Spike RBD - Redacted.ND. Order Form - Provision of purchase of SARS-CoV-2 (2019-nCoV) Spike RBD REDACTED_Redacted.pdf

Reference

Domains